Showing results (51-60 of 112) with videos related to
Sort By:
Pageof 12
Molecular & Cellular Proteomics : MCP|February 17, 2012
Human biomarker discovery and predictive models for disease progression for idiopathic pneumonia syndrome following allogeneic stem cell transplantationDaniela M Schlatzer, Jean-Eudes Dazard, Rob M Ewing, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndromeGerhard C Hildebrandt, Leigh A Corrion, Krystyna M Olkiewicz, et al.Transplantation|September 28, 2004
A role for tumor necrosis factor-alpha-mediated endothelial apoptosis in the development of experimental idiopathic pneumonia syndromeArmin Gerbitz, Brian J Nickoloff, Krystyna Olkiewicz, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 9, 2020
Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials NetworkJohn E Levine, Joseph H Antin, Carl E Allen, et al.Blood Advances|April 19, 2024
Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignanciesPhilip H Imus, Sergiu Pasca, Hua-Ling Tsai, et al.Blood Advances|January 22, 2026
Bone marrow transplantation for sickle cell disease using post-transplantation cyclophosphamide and 400 cGy TBIMarti Goldenberg, Ravi Varadhan, Christopher J Gamper, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2015
Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic MalignanciesElad Jacoby, Allen Chen, David M Loeb, et al.Blood Advances|June 10, 2026
PT/Cy-based alloBMT platform as a curative, accessible alternative for pediatric and young adult severe aplastic anemiaMargarita Dionysiou, Yiouli P Ktena, Challice L Bonifant, et al.Blood|July 31, 2008
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationGregory A Yanik, Vincent T Ho, John E Levine, et al.Pediatric Blood & Cancer|September 22, 2016
Tolerance and effectiveness of nivolumab after pediatric T-cell replete, haploidentical, bone marrow transplantation: A case reportAziza T Shad, Jeffrey S Huo, Courtney Darcy, et al.Pageof 12